Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (10335)	7/1/1998 11:12:00 PM
From: Cacaito	Read Replies (1) \| Respond to of 23519

BigKNY3, Viagra is most probably than not here to stay. My chances are 100,000,000 to 1 for viagra staying, So any Vivus investment based on the ban of Viagra is worst than Lotto. Anyway, if Viagra is ban by the FDA they will have a bigger headache, a totally clandestine market, no way to stop this madness, the control will be the lawsuits against physicians and the healthy fear of patients and physicians alike. Muse has been used by more than 600,000 patients and the FDA investigated one death, the famous old man who used Muse more than 200 times before his death. Viagra patients deaths are playing in the big leagues in heaven after the first hit. Exercise related death is theoretically (and so far in the practical experience in the market) higher with viagra than Muse, the systemic effect of Viagra probably account for it. Viagra works 70% at best? overall about 50%? the rest is for Muse/Caverject market. Millions of free sample pills are flooding the US and the world. Myself got hold of 30 free pills and my friends back in my Caribean Island are enjoying then. Many Muse patients are in their free Viagra honeymoon, most of then maybe forever marriage. The Viagra effect on Muse is so far disastrous and who knows if it will change for good. That Pfizer avoided the sickest patients in the trials was completely right. Zonagen did the same and it was also right. Physicians are responsible for educating themselves. Big Pharma is not great on education quality, but I still put the responsibility on physicians. My friend got afraid when his first patient asked for Viagra, he sent him to the Urologist (healthy fear due to previous legal problem with Prozac, he won but still remember). I am hoping for 20,000,000 million patients worldwide for Pfizer's Viagra and maybe 1 million for Vivus in 5 years. IF, IF, IF the famous US 30,000,000 ED patients are for real. Are outside there 30,000,000 million US and 100,000,000 worldwide impotent men? This is the figure the market is based on, But what about if this is not true and what the 2.5 million US prescriptions of viagra is as good as it gets? Well if it is true for viagra should be for Vvus. Shorting PFE is wise if one does not belief those numbers. Otherwise I would not dare to short it (except short term bursts up and down). BigKNY3, thank you for your temperate responses in the past. And your healthy fear of Vivus the stock. Please, inform when are you buying again, last time your timing was good. Are outside there 30 (US) to 100 (World) millions of ED patients? That is the question. Still Long face Vvus. Cacaito